Isolation of Anti-SARS-CoV-2 Natural Products Extracted from <i>Mentha canadensis</i> and the Semi-synthesis of Antiviral Derivatives
Osbert Chou, Yu-Pu Juang, Tai‐Ling Chao, Sheng‐Fa Tsai, Pei-Fang Chiu, Chun‐Tang Chiou, Keng‐Chang Tsai, Sui‐Yuan Chang, Pi‐Hui Liang, Chi‐Huey Wong
Abstract
Traditional herbal medicine offers opportunities to discover novel therapeutics against SARS-CoV-2 mutation. The dried aerial part of mint ( Mentha canadensis L.) was chosen for bioactivity-guided extraction. Seven constituents were isolated and characterized by nuclear magnetic resonance (NMR) and mass spectrometry (MS). Syringic acid and methyl rosmarinate were evaluated in drug combination treatment. Ten amide derivatives of methyl rosmarinate were synthesized, and the dodecyl ( 13 ) and 3-ethylphenyl ( 19 ) derivatives demonstrated significant improvement in the anti-SARS-CoV-2 plaque reduction assay, achieving IC 50 of 0.77 and 2.70 μM, respectively, against Omicron BA.1 as compared to methyl rosmarinate’s IC 50 of 57.0 μM. Spike protein binding and 3CL pro inhibition assays were performed to explore the viral inhibition mechanism. Molecular docking of compounds 13 and 19 to 3CL pro was performed to reveal potential interaction. In summary, natural products with anti-Omicron BA.1 activity were isolated from Mentha canadensis and derivatives of methyl rosmarinate were synthesized, showing 21- to 74-fold improvement in antiviral activity against Omicron BA.1.